Coronavirus Live Count Map India
remove_red_eye 737 Views
COVID-19 Vaccine Updates
#Business And Medicine #Hematology #Obstetrics and Gynecology #Oncology #Public Health
An HPV vaccine which may act against persistent HPV infections and reduce the risk of women developing cervical cancer is going to be tested in clinical trial. Human papilloma virus infections occur commonly, but about 10% of infections are not cleared, with persistent infection of some types of HPV known to increase the risk of number of cancers, including cervical cancer. The new trial, expected to begin in March, is an international endeavor planned to involve 15 hospitals from UK and Belgium.